Acompanhe as Notícias da Recifes

A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the ther

New research published in Neuro-Oncology offers a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes.

Scientists in Britain and Spain have discovered critical windows after glioblastoma surgery when the brain's defenses falter, creating a rare chance to deliver powerful treatments exactly where needed. If doctors time treatment within two narrow postoperative windows identified b

Glioblastoma is a malignant brain tumor and is among the most aggressive cancers in humans. Despite multimodal therapy with surgery, radiation and chemotherapy, there is still no cure. A major reason is the tumor's invasive behavior: Glioblastoma cells migrate far beyond the visi

Researchers from the Clinical Neuroscience Consortium (CNC), a collaborative platform jointly established by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and Queen Mary Hospital, in collaboration with the Hong Kong Genome Institute (HKGI), have developed th

University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer. The approach could overcome many of the limitations of treatments using existing drugs.

A new experimental treatment may have found a way to outsmart glioblastoma’s toughest defense: the blood-brain barrier. Researchers used sugar-coated nanoparticles to ferry genetic instructions that restore a key tumor-suppressing protein directly into brain cancer cells. In mous

Researchers have identified a critical biological difference in how glioblastoma develops in male and female laboratory models, pinpointing an immune pathway that fuels tumor growth only in females. The study shows that the neurotransmitter GABA boosts the cancer-protecting activ

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i

Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to their study published in Nature Communications.

She was diagnosed with a glioblastoma, a highly aggressive brain tumour, in June 2022. O recorte ajuda a contextualizar a pauta dentro de Beleza.